Veterans Healthcare System, Little Rock, Arkansas, USA first evidence of cisplatin-induced induction of the Akt/PKB Role and regulation of activation of caspases in cisplatin-induced phosphorylation pathway, inhibition of which enhances activainjury to renal tubular epithelial cells. tion of caspase-3 and caspase-9. Background. Cellular and molecular mechanisms responsible for cisplatin-induced nephrotoxicity to renal tubular epithelial cells are not well understood. Although caspases play a critical role in the execution of the cell death pathway, their specific The chemotherapeutic drug cisplatin, commonly used role in toxic injury to renal tubular epithelial cells has not been for the treatment of solid tumors of a wide range of tiselucidated previously. sues [1-3], is generally associated with nephrotoxicity as Methods. The role of caspases in cisplatin-induced injury was determined using caspase inhibitors and p35 transfected one of its major side effects. The primary targets of cis-LLC-PK1 cells. The Akt/PKB phosphorylation pathway was platin in kidney are the proximal tubular epithelial cells studied for the regulation of caspase activation in these cells.
Caspases (originally known as interleukin 1␤-convertagainst DNA damage. We then examined the role of the Akt/ PKB phosphorylation pathway in regulation of cisplatin-induced ing enzyme and its family of proteases) are a family of caspase activation. There was a marked induction of Akt/PKB cell death proteases [5] that plays an essential role in the phosphorylation in a time (0 to 8 hours) and dose-dependent execution phase of apoptosis [6] [7] [8] [9] [10] [11] . Thus far, 14 mem-(0 to 200 mol/L) manner during the course of cisplatin injury. bers of the caspase family have been identified from Cisplatin-induced Akt/PKB activation was associated with Bad mammalian cells [11, 12] . Caspase-8, -9, -10, and -2 have phosphorylation, suggesting induction of a cell survival signal mediated by the Bcl-2 family member, Bad. Wortmannin or large prodomains and initiate the activation of down-LY294002, two structurally dissimilar inhibitors of phosphatistream caspases, and caspase-3, -6, and -7 with smaller dodylinositol 3Ј-kinase (PI-3 kinase), abolished both cisplatinmains are identified as executioner caspases [11] . The induced Akt phosphorylation and Bad phosphorylation, and downstream executioner caspase-3 is responsible for the promoted cisplatin-induced early and accelerated activation of cleavage of a wide variety of physiological substrates caspase-3 and caspase-9, but not of caspase-8 and caspase-1, indicating that inhibition of the Akt/PKB phosphorylation including DNA repair enzymes [13, 14] , ICAD (inhibitor pathway enhances the mitochondrial-dependent activation of of caspase-activated DNase) or DNA fragmentation faccaspases. The impact of enhanced activation of caspases by tor [15, 16] , nuclear structural proteins [11, 17] , and cytowortmannin or LY294002 was reflected on accelerated cisskeleton proteins [11, 18, 19] . At present, there are two platin-induced cell death.
relatively well-characterized cell death pathways that re-Conclusions. These studies demonstrate differential activation and role of caspases in cisplatin injury, and provide the sult in the activation of downstream or executioner caspases. One is receptor-mediated and the other is mitochondrial-dependent. The receptor-dependent pathway [20] [21] [22] . The mitochondrial-dependent pathway is triggered by cytochrome c release from the mitochondria  2001 by the International Society of Nephrology that promotes the activation of procaspase-9 through pase inhibitors, DEVD-CHO, IETD-CHO, and LEHD-CHO were purchased from Bachem Inc. (Torrance, CA, Apaf-1 and dATP. Activated caspase-9 then cleaves and activates the downstream pro-caspase-3 [23] [24] [25] . How-USA) and ZVAD-FMK was from Enzyme Systems products (Dublin, CA, USA). Caspase substrates were pur-ever, whether cisplatin-induced activation of caspases are involved with these signaling pathways is not known. chased from Peptide International (Louisville, KY, USA) and antibodies to caspases were from Santa Cruz Currently, there is limited information on the role of caspases in cisplatin-induced renal tubular epithelial Biotechnology (Santa Cruz, CA, USA). Anti-Akt, antiser-473-phosphorylated Akt, anti-Bad, anti-ser-136 phos-(RTE) cell injury. Cisplatin has been shown to induce cell death in renal tubular epithelial cells [26] [27] [28] [29] [30] . Caspase-3 phorylated Bad, anti-ser-112 phosphorylated Bad antibodies were obtained from Cell Signaling Technology is activated in renal proximal tubular cells [31, 32] by cisplatin treatment, suggesting that cisplatin-induced cell (Beverly, MA, USA). Expression plasmid for p35 and antibody to p35 were kindly provided by Dr. Anu Srini-death is mediated by caspases. We have previously demonstrated that renal tubular epithelial cells transcribe vasan, Idun Pharmaceuticals (La Jolla, CA, USA). and express multiple caspases, including the initiator and Treatment with cisplatin executioner caspases [33] . However, there is no information on the specific role and regulation of the underlying Cells were replaced with fresh DMEM containing serum, glutamine, pyruvate, nonessential amino acids, glu-mechanism(s) of signaling pathways responsible for the activation of caspases in cisplatin-induced cellular injury. cose, 3.7 g/L NaHCO 3 and 20 mmol/L HEPES at pH 7.4 and incubated either with or without cisplatin of various Cells have inherited information to initiate the apoptotic pathway in response to a death stimuli unless they concentrations for the period of time indicated. In initial studies, we determined the optimum exposure time and are challenged by cell survival signals that maintain cell viability. On receiving a death stimulus, both cell death the suitable concentration of cisplatin. To determine a role of caspases in cisplatin-induced cell death, cells were and cell survival pathways can be induced during the course of cellular injury. Therefore, the extent of cellular preincubated with caspase inhibitors, DEVD-CHO for caspase-3 and LEHD-CHO for caspase-9 for 30 minutes, injury caused by a toxic agent will depend on the balance between activation of caspases triggered by toxic injury washed, and exposed to cisplatin (50 mol/L). and on the induction of survival factors capable of block-Determination of caspase activity ing the activation of caspases. At present, there is no information on the induction of survival signals that regu-Cells were harvested by centrifugation and the pellets were washed in cold phosphate-buffered saline (PBS) late caspase activation during cisplatin-induced cellular injury. The present study provides evidence that cisplatin twice. The washed cell pellets were lysed with 20 mmol/L HEPES, pH 7.5, containing 10% sucrose, 0.1% CHAPS-not only triggers selective and differential activation of caspases but also causes induction of the PI3/Akt path-3 -[(3 -cholamidopropyl)dimethylamino-1]propane -sulfonate), 2 mmol/L dithiothreitol (DTT), 0.1% NP40, way of cell survival, a signaling pathway previously unrecognized in cisplatin-induced cellular injury. The studies 1 mmol/L ethylenediaminetetraacetic acid (EDTA), 1 mmol/L phenylmethylsulfonyl fluoride (PMSF), 1 g/mL also demonstrate the specific role of executioner caspase-3 and enhanced activation of this caspase and the leupeptin, and 1 g/mL pepstatin A at 4ЊC. The supernatants obtained after centrifugation were used to deter-initiator caspase, caspase-9, by inhibition of the PI-3 kinase/ Akt phosphorylation pathway during cisplatin-induced mine the enzyme activity. The activities of caspase-1, -2, -3, -8, and -9 were determined by fluorometric as-injury to renal tubular epithelial cells. say using the substrates; YVAD-AMC for caspase-1, VDVAD-AMC for caspase-2, DEVD-AMC for caspase-METHODS 3, LEHD-AMC for caspase-9, and IETD-AMC for cas-Cell culture and reagents pase-9, which are specifically cleaved by the respective enzymes at the Asp residue to release the fluorescent LLC-PK 1 cells obtained from American Type Culture Collection (Rockville, MD, USA) were cultured as in our leaving group, amino-4-methyl coumarin (AMC) [35, 36] . The enzyme extracts containing 50 g protein were previous studies [34] . The cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with incubated with 100 mmol/L HEPES, pH 7.4, containing 10% sucrose, 0.1% CHAPS, 10 mmol/L DTT, and 50 10% heat-inactivated fetal calf serum, 2 mmol/L l-glutamine, 20 mmol/L 4-(2-hydroxy ethyl)-1-piperazine ethane-mol/L of caspase substrate in a total reaction volume of 0.25 mL. The reaction mixture was incubated for 60 sulfonic acid (HEPES), and 2 mmol/L nonessential amino acids. Cultures were maintained in a humidified incuba-minutes at 30ЊC. At the end of incubation, the liberated fluorescent group AMC was determined using a fluores-tor gassed with 5% CO 2 and 95% air at 37ЊC and fed with fresh medium at intervals of 48 to 72 hours. Experiments cent Spectrofluorometer (Perkin Elmer) with an excitation wavelength of 380 nm and an emission wavelength were performed with cells grown to 80% confluence. Cas-of 460 nm [36] . AMC was used as a standard. Based on containing 10% isopropanol and destained in the same solvent without Coomassie blue. the standard curve made with fluorescence reading with free AMC, the data for caspase activity are expressed Western blot analysis as nmol of AMC liberated when 50 g of protein extract was incubated with 50 mol/L of substrate for 60 minutes
The cell lysates were prepared as described previously in this article for caspase assay and 100 g protein sam-at 30ЊC.
ples were subjected to reducing SDS-gel electrophoresis.
Determination of DNA damage
The resolved proteins were electrophoretically transferred to Immobilon polyvinylidine difluoride (Millipore, Bed-The residual double-stranded DNA was measured by the alkaline unwinding assay and determination of ethid-ford, MA, USA) membrane and processed further for antibody staining as described by Towbin, Staehelin and ium bromide fluorescence according to the method of Birnboim and Jevcak [37] , as utilized in our previous stud-Gordon [40] . Following this transfer, the membranes were washed in a buffer containing 50 mmol/L Tris-HCl, ies [38, 39] . Ethidium bromide fluorescence was measured at 520 nm excitation and 590 nm emission using pH 7.5, 150 mmol/L NaCl, and 0.05% Tween 20 for five minutes, and then in the same buffer containing 5% non-a fluorescence spectrophotometer. Under the conditions employed, ethidium bromide binds preferentially to dou-fat dry milk for an hour at room temperature. The membranes were then incubated for five hours with antibodies ble-stranded DNA. Percent double-strand DNA (D) was determined by the equation: %D ϭ 100 ϫ [F(P) Ϫ F(B)]/ to caspases (usually 1:1000 dilution) in the same buffer with 5% dry milk as described previously in this article.
The incubations were done at room temperature on a platform shaker to ensure thorough mixing. At the end of this and F(B) is the background fluorescence that was obtained from sonicated, alkaline-treated DNA, a condi-time, the membranes were thoroughly washed (at least 4 times) with 50 mmol/L Tris-HCl, pH 7.5, containing tion under which the DNA is completely unwound and represents the fluorescence due to all components other 0.05% Tween 20. The membrane filters were then incubated for two hours with horseradish peroxidase-conju-than double-stranded DNA.
gated goat anti-rabbit antibody diluted 1:3000 in Tris buf-Detection of DNA fragmentation by agarose fer containing 5% dry milk. After incubation, membrane gel electrophoresis filters were washed in the same buffer (50 mmol/L Tris-HCl and 150 mmol/L NaCl only) containing 0.05% Tween To assess DNA fragmentation, fragmented DNA was isolated from LLC-PK1 cells as previously described 20 and developed by exposure to chemiluminescent substrates (Pierce, Rockford, IL, USA). [38, 39] . Cells were collected by centrifugation at 200 ϫ g for 10 minutes, and the pellets were lysed with 1.0 mL Overexpression of p35 of lysis buffer containing 0.5% Triton X-100, 10 mmol/L Tris-HCl, pH 8.0, 25 mmol/L EDTA for one to two hours LLC-PK1 cells were transfected with expression plasmid pcDNA-3 containing the p35 full-length cDNA. p35 at 4ЊC. The lysates were centrifuged at 16,000 ϫ g for 20 minutes to separate the fragmented DNA (superna-viral protein has been reported to be an effective inhibitor of caspase-3 [41] [42] [43] . Transfection was performed us-tant) from the intact DNA (pellet). The resulting supernatant containing fragmented DNA was incubated with ing Lipofectamine (Life Technologies, Grand Island, NY, USA) as per the manufacturer's recommendation. In brief, proteinase K (200 g/mL) at 50ЊC overnight. The DNA was extracted with phenol-chloroform-isoamyl alcohol cells were plated at a density of 2 ϫ 10 5 in six-well plates. After 24 hours, cells were washed thrice with serum-free (50:49:1), followed by precipitation with 0.1 volumes of 3 mol/L sodium acetate and 2.5 volumes of 100% etha-media and incubated for five hours with a mixture of Lipofectamine and plasmids containing the inserts (1.5 L nol. The samples were suspended in 10 mmol/L Tris-HCl, pH 7.5, containing 0.5 mmol/L EDTA. The concentra-of Lipofectamine, 50 L of serum-free medium and 1 g of DNA in 50 L of serum-free medium) in serum-free tion of nucleic acid in each sample was determined by ultraviolet absorbance at 260 nm. The fragmented DNA media at 37ЊC with 10% CO 2 . Cells were then grown in the presence of G418 and selected for G418-resistant isolated from each sample was treated with RNAse (20 g/mL) at 37ЊC for three hours and subjected to clones. After cell recovery, cells were examined for the expression of p35 A by Western blot using p35 antibody. electrophoresis on a 1% agarose gel. After electrophoresis, the DNA was visualized by ultraviolet fluorescence
The transfected cells were also examined for the suppression of caspase-3 activity using the fluorogenic substrate after staining with ethidium bromide.
Sodium dodecyl sulfate (SDS) polyacrylamide gel elec-DEVD-AMC. These cells were then used to examine the protection against cisplatin-induced injury. After variable trophoresis (PAGE) was performed as previously described [33] using 8% polyacrylamide gels. The gels were periods of cisplatin treatment, DNA damage and cell death were determined in the over-expressing cells as described stained with 0.05% Coomassie blue in 10% acetic acid caspase-2, respectively, also were increased but to lesser (᭡) VDVAD-MCA, caspase-2; () LEHD-MCA, caspase-9; (᭡) degree than caspase-3 ( Fig. 1) . However, the activity of IETD-MCA, caspase-8; (᭜) YVAD, caspase-1.
proinflammatory caspase-1 [11] was not detected in cisplatin-treated cells, indicating that cisplatin does not activate proinflammatory caspase-1. The substrate specificity in our studies [34] and compared to control cells to examof the caspases may be promiscuous, but was overcome ine the effect of the inhibitor in this model of injury. by identifying the activation by Western blot analysis (discussed later in this article) using specific antibodies to Statistical analyses each caspase. The cisplatin-induced activation of caspases Results are mean Ϯ SE. Comparison between values was suppressed by peptide inhibitors of caspases (Fig. 2) . was determined by the Student t test. A P value of less Caspases are synthesized as inactive proenzymes and than 0.05 was considered significant.
in response to an apopoptotic stimuli are activated by proteolytic processing of the proenzyme. In the process of activation the inactive proenzyme is proteolytically RESULTS cleaved to the smaller subunits of about 20 and 10 kD Role of caspases in cisplatin-induced injury in size [11] . In response to an injury, the identity of the To elucidate the role of caspases in cisplatin-induced active form of the caspase produced can be revealed by injury to LLC-PK1 cells, we first examined the activity Western blot analysis using a specific antibody to the of the initiator caspases, caspase-9, -8, -2, and the execucaspase. Thus, to examine the exact identity and activationer caspase, caspase-3 in response to cisplatin injury to tion of initiator and executioner caspases during cis-LLC-PK1 cells. The activity of caspases was determined platin-induced injury to LLC-PK1 cells, we performed using fluorometric peptide substrates specific for each of Western blot analysis using specific antibodies to casthe caspases. As shown in Figure 1 , the activity of DEVDpase-3, -8, and -9. As shown in Figure 3 , proteolytic AMC cleavage began at approximately eight hours of processing of procaspase-3 results in the formation of a cisplatin treatment and then significantly increased with 17 kD subunit of the active caspase-3. This activation increasing periods of cisplatin (50 mol/L) treatment, began at eight hours of cisplatin (50 mol/L) treatment suggesting the activation of caspase-3. The maximal actiand thereafter progressively increased up to 24 hours of vation occurred at 24 hours of cisplatin treatment. The the treatment. Caspase-8 was also proteolytically proactivities of cleavage of IETD-AMC, LEHD-AMC, and cessed as shown by the gradual decrease in the band of its proform (the antibody to caspase-8 used was specific VDVAD-AMC substrates for caspase-8, caspase-9, and to the proform only and did not recognize the processed subunits; Fig. 3) . Similarly, caspase-9 was proteolytically processed to result in a 37 kD (prodomain ϩ large fragment) and a 17 kD subunit of the active form. Moreover, activation of caspase-8 and -9, respectively. The data presented in Figures 1 and 3 show that activation of caspase-3 may precede that of caspase-8 and -9, suggesting that this activation of caspase-3 may be contrib-3, P Ͻ 0.002) and as determined by DNA fragmentation uted by an unknown pathway or other caspases. pattern on agarose-gel electrophoresis (Fig. 5 ). Since cowpox viral protein is a potent inhibitor of caspase-3 [41] [42] [43] , we developed a stably transfected LLC-
Induction of cisplatin-induced PI-3 kinase/ PK1 cell line that overexpressed the p35 caspase inhibi-
Akt phosphorylation and its effect on tor. The transfected cells provided marked protection caspase activation and cell death against cisplatin-induced cell death (Fig. 4A ). Peptide
The serine/threonine kinase Akt is one of the downinhibitors of caspase-3 and caspase-9 also provided sigstream targets of phosphatidylinositol 3Ј-kinase (PI-3 kinificant protection against cisplatin-induced cell death in nase) [44, 45] and PI-3 kinase-dependent Akt phosphory-LLC-PK1 cells (Fig. 4B ). However, inhibition of caspases lation provides an important mechanism for resistance provided partial protection against cisplatin-induced to cell death in response to injury [44, 46] . Phosphoryla-DNA damage as measured by DNA unwinding assay tion of Akt leads to full activation of Akt that can result (residual double-stranded DNA in control cells, 95 Ϯ in phosphorylation of its direct downstream target, Bad, 3%; 50 mol/L cisplatin, 46 Ϯ 2%; 50 mol/L cisplatin ϩ a member of the Bcl-2 family [47-49]. When phosphorylated, Bad dissociates from Bcl-XL or Bcl-2 [50] and re-25 mol/L DEVD-CHO, 72 Ϯ 3%; p35, 77 Ϯ 2%; N ϭ not changed during the course of cisplatin injury. Since activated Akt can phosphorylate Bad, we examined the time course of Bad phosphoryation in cisplatin-induced injury. As shown in Figure 7 , Bad phosphorylation was markedly increased at least up to eight hours of cisplatin treatment and then declined in longer periods. These studies indicate that Bad phosphorylation is associated with Akt phosphorylation during cisplatin-induced injury and may be involved in the suppression of caspase activation in early time periods (at least up to 8 hours) of cisplatin treatment. Indeed, phosphorylation of both Akt and Bad were abolished in a dose-dependent manner by LY294002 (0 to 10 mol/L; Fig. 8 ) or by wortmannin (0 to 0.25 mol/L; data not shown), inhibitors of PI-3 kinase. Since Akt phosphorylation is known to block apoptosis and promote cell survival [44, 46] , the inhibition of Akt phosphorylation should potentiate enhanced caspase activation during the course of cisplatin injury. As shown in Figure 9 , wortmannin (0.25 mol/L) resulted in an early and enhanced increase in cisplatin-induced caspase-3 and caspase-9 activation compared with the activation by cisplatin alone in a time-(0 to 24 hours; Fig. 9A ) and dose-dependent (0 to 100 mol/L of cisplatin for 12 hours) manner (Fig. 9B ). Wortmannin (0.25 mol/L) alone (as shown in Fig. 9B at zero cisplatin concentration) slightly increased caspase-3 and caspase-9 activation, but this activation was far less compared to the activation by cisplatin alone or by wortmannin and cisplatin together. Thus, these studies indicate that inhibition of Akt phosphorylation enhance mitochondrial-dependent caspase-9 and caspase-3 activation in cisplatin-induced injury. In marked contrast, inhibition of Akt phosphorylation did not affect the cisplatin-induced caspase-8 and proinflammatory caspase-1 activities (Fig. 10) . Thus, the receptor-mediated pathway that activates procaspase-8 and proinflammatory caspase-1 are not affected by inhibition of Akt phosphorylation in cisplatin-induced injury. These studies indicate that
Fig. 5. Effect of caspase inhibition on cisplatin-induced DNA fragmen-
Akt phosphorylation regulates the mitochondrial-depentation. Lanes are: C; control, CP (50 mol/L); cells were exposed to 50 mol/L cisplatin for 20 hours. CP (50 mol/L)ϩI (25 mol/L); cells dent caspase-9 and caspase-3 activation in cisplatin-induced were exposed to 50 mol/L cisplatin and 25 mol/L of DEVD-CHO injury. We next examined the effect of LY294002 on the for 20 hours. CP (50 mol/L) ϩ p35; p35 transfected cells exposed to cisplatin-induced proteolytic processing of caspase-3 and 50 mol/L cisplatin for 20 hours. The fragmented DNA was isolated from each sample as described in the Methods section and subjected caspase-9 from their proforms to the active forms. This to 1% agarose gel electrophoresis and visualized with ethidium bromide. was done by Western blot analysis using specific antibodies to caspase-3 and caspase-9. As shown in Figure 11 , LY294002 (5 mol/L) resulted in the appearance of active caspase-3 and caspase-9 as early as two hours of stores their antiapoptotic function by preventing caspase-9 activation and, subsequently, caspase-3 activation [51 -53] .
cisplatin treatment and enhanced activation of these caspases in later time points. These data suggest that Thus, we first examined cisplatin-induced Akt phosphorylation and consequential Bad phosphorylation, and then inhibition of the PI-3 kinase/Akt pathway not only results in earlier activation of caspase-3 and -9 but also the downstream effects of this phosphorylation on suppression of caspase activation. Western blot analysis using at higher levels in cisplatin-induced injury to renal tubular epithelial cells. The inhibition of cisplatin-induced anti-phospho Akt antibody revealed a marked increase in cisplatin-induced Akt phosphorylation in a time-and Akt phosphorylation was also reflected in early and enhanced cell death (Fig. 12 ). Figure 12 shows that cis-dose-dependent manner (Fig. 6) . However, the protein expression of Akt as determined using Akt antibody was platin-induced cell death is markedly enhanced by inhibi- tion of Akt phosphorylation. These studies indicate that enhanced activation of caspase-3 and caspase-9 by inhibition of Akt phosphorylation also has an impact on cis- naling pathways responsible for the regulation of downstream caspase-3 and other upstream caspases that may be activated during cisplatin-induced injury to renal tubular epithelial cells. Our data indicate that cisplatin activation of these caspases was markedly inhibited by their respective peptide inhibitors, suggesting that these induces selective and differential activation of caspases including executioner caspase-3 and initiator caspase-8 caspases may play an important role in cisplatin-induced injury to renal tubular epithelial cells. DEVD-CHO or and -9, but not proinflammatory caspase-1. The selective LEHD-CHO, inhibitors of caspase-3 and caspase-9, re-cating that Akt phosphorylation is dependent on the activation of PI-3 kinase. Akt (also known as protein kinase B) spectively, provided marked protection against cisplatininduced cell death and partial protection against DNA was originally identified as the cellular homolog of the transforming oncogene of the AKT8 retrovirus [58, 59] . damage in LLC-PK1 cells as revealed by an alkaline unwinding assay and by agarose gel electrophoresis. The Recent studies from several laboratories have recognized PI-3 kinase/Akt phosphorylation as one of the signaling specific role of caspase-3 and its more direct involvement in cisplatin-induced injury came from studies utilizing pathways that blocks apoptosis and promotes cell survival in response to diverse apoptotic stimuli in different the baculovirus protein p35, which is a potent inhibitor of caspase-3 [42] [43] [44] . Over-expression of p35 blocks the cell types [44-47, 60, 61] . However, the role of Akt phosphorylation in determining the cell fate in cisplatin-induction of apoptosis in insect and mammalian cells [54] [55] [56] . Thus, a stably transfected LLC-PK1 cell line de-induced injury is not known. Several pathways have been proposed for PI-3/Akt phosphorylation-mediated cell veloped to over-express p35 was capable of providing protection against cisplatin-induced injury indicating that cis-survival [44] . One of the well-studied molecules that mediates cell survival by Akt phosphorylation is the pro-platin injury involves the participation of caspases.
Our studies also show that cisplatin induces the phos-apoptotic Bcl-2 family member Bad. Bad has the ability to directly interact and bind to antiapoptotic Bcl-2 and phorylation of the antiapoptotic serine/threonine kinase Akt and that this phosphorylation is inhibited by PI-3
Bcl-XL and blocks their survival function [50, 54, 61, 62] . Phosphorylated Akt can directly phosphorylate Bad both kinase inhibitors LY294002 and wortmannin [57] , indi- tion of Akt modulates the response to cisplatin injury.
The apoptotic pathway is a highly regulated process and cells have inherited information to initiate this pathin vitro and in vivo [47, 48, 61] , and may render Bad way in response to a death stimulus. Once initiated by an incapable of binding to Bcl-XL and restore the antiapoapoptotic stimulus, the cell death pathway can be chalptotic function of Bcl-2 [44, 62] . Sequestering phosphorylenged by cell survival signals to overcome injury and mainlated Bad by 14-3-3 proteins [50, 61] also may participate tain cell viability. Thus, the extent of cell injury caused by in the Akt survival pathway by making it unavailable to a toxic agent will depend on the balance between activabind to Bcl-2 or prevent it from damaging the mitochontion of caspases triggered by a toxic agent and on the dria. Many studies have provided evidence that Bcl-2 induction of survival signals capable of blocking the acfamily members regulate activation of caspases through tivation of caspases. The data presented in this article control of cytochrome c release from the mitochondria clearly demonstrate that cisplatin not only triggers cas-[51, 62] and by directly binding to Apaf 1, thus preventing pase activation, but also causes induction of the PI-3 the activation of procaspase-9 and subsequently caspase-3 kinase/Akt pathway and impacts on cell survival. These [53] . Our study presents evidence that PI-3 kinase-mediobservations have not been previously recognized in reated Akt phosphorylation is associated with Bad phosnal tubular epithelial cell injury. Our studies thus provide phorylation and suppression of caspase-9 and caspase-3 new targets to modulate cisplatin-induced injury to renal activation. Indeed, our studies show that wortmannin tubular epithelial cells. It is possible that enhancing the and LY294002, inhibitors of PI-3 kinase block cisplatinrenal-specific cell survival signals and inhibiting death induced phosphorylation of both Akt and Bad and ensignals will lead to preservation of renal function in toxic hance activation of caspase-9 and caspase-3 by cisplatin.
injury. On the other hand, these inhibitors had no effect on the activation of proinflammatory caspase-1 and receptor-ACKNOWLEDGMENTS dependent initiator caspase-8. A recent study has shown platin-induced toxicity in the renal epithelial cell line LLC-PK1:
